Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Nordic Life Sciences A/S
A/S
Active
Reklamebeskyttelse
CVR 41727659
Langehede 103A, 5471
Søndersø
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2020 · 5 years old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Nordic Life Sciences A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2021
-2M
2022
-4M
2023
-11M
2024
-9M
2025
EBITDA
DKK millions
0M
-4M
-9M
-13M
-18M
-1M
2021
-5M
-400%
2022
-5M
0%
2023
-14M
-180%
2024
-12M
+14%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-1.050
-2.427
-4.004
-10.527
-8.873
Staff expenses
-0
-2.556
-1.223
-3.198
-2.759
EBITDA
-1.050
-4.983
-5.228
-13.726
-11.632
Depreciation & amort.
-0
-0
-0
-0
-31
EBIT
-1.050
-4.983
-5.228
-13.726
-11.663
Net financials
0
-21
-20
-50
35
Profit before tax
-1.050
-5.004
-5.247
-13.775
-11.628
Tax
-0
-0
-1.975
-2.725
-2.328
Net profit
-1.050
-5.004
-3.272
-11.050
-9.300
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
0
3.321
2.628
7.062
6.689
Equity
-1.010
-6.014
-8.927
-19.975
-13.918
Long-term debt
0
0
0
0
0
Short-term debt
1.010
9.336
11.555
27.037
20.607
Total debt
1.010
9.336
11.555
27.037
20.607
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-1163190900.0%
This company
2021
2025
Soliditetsgrad
-208.1%
This company
38.2%
Market median
-645% vs market
2021
2025
Egenkapitalforrentning
-929971600.0%
This company
18.4%
Market median
-5054193578% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-929971600.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
-1.33×
This company
2021
2025
Gæld/egenkapital
1.48×
This company
0.62×
Market median
-139% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-09-24 – 2021-06-30
View
PDF
More on Nordic Life Sciences A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
